These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 23386486)
1. An inflammatory myofibroblastic tumour of the breast with ALK overexpression. Zhou Y; Zhu J; Zhang Y; Jiang J; Jia M BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23386486 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification. Wang K; Guo R; Siegal GP; Wei S Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196 [TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Cook JR; Dehner LP; Collins MH; Ma Z; Morris SW; Coffin CM; Hill DA Am J Surg Pathol; 2001 Nov; 25(11):1364-71. PubMed ID: 11684952 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524 [TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Freeman A; Geddes N; Munson P; Joseph J; Ramani P; Sandison A; Fisher C; Parkinson MC Mod Pathol; 2004 Jul; 17(7):765-71. PubMed ID: 15105807 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312 [TBL] [Abstract][Full Text] [Related]
9. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor. Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation. Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory myofibroblastic tumour (inflammatory pseudotumour) of the breast. Clinicopathological and genetic analysis of a case with evidence for clonality. Sastre-Garau X; Couturier J; Derré J; Aurias A; Klijanienko J; Lagacé R J Pathol; 2002 Jan; 196(1):97-102. PubMed ID: 11748648 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068 [TBL] [Abstract][Full Text] [Related]
15. Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene. Saiki M; Ohyanagi F; Ariyasu R; Koyama J; Sonoda T; Nishikawa S; Kitazono S; Yanagitani N; Horiike A; Ninomiya H; Ishikawa Y; Nishio M Jpn J Clin Oncol; 2017 Dec; 47(12):1189-1192. PubMed ID: 28977547 [TBL] [Abstract][Full Text] [Related]
16. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report. Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970 [TBL] [Abstract][Full Text] [Related]